drugset / Trial / NCT02716129
The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary endpoint of this study is to investigate the effect of adding nalbuphine to intrathecal morphine on quality of postoperative analgesia and Morphine related side effects post- cesarean delivery.
Timeline
- Start
- 2016-07
- Primary completion
- 2017-10
- Completion
- 2017-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 0.2 mg | Intrathecal |
| Comparator | Morphine | Other / unclassified | 0.5 mg | Intrathecal |
| Comparator | Nalbuphine | Small molecule | 0.2 mg | — |
| Comparator | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |
Indications
No indication recorded.